CAS 1009816-48-1

Formule : C9H16N2O4S

InChI : InChI=1S/C9H16N2O4S/c1-2-10-9-11-5-7(14)6(13)4(3-12)15-8(5)16-9/h4-8,12-14H,2-3H2,1H3,(H,10,11)/t4-,5-,6-,7-,8-/m1/s1

Code InChI : PPAIMZHKIXDJRN-FMDGEEDCSA-N

SMILES : CCN=C1N[C@@H]2[C@H]([C@@H]([C@H](O[C@@H]2S1)CO)O)O

5H-Pyrano[3,2-d]thiazole-6,7-diol, 2-(ethylamino)-3a,6,7,7a-tetrahydro-5-(hydroxymethyl)-, (3aR,5R,6S,7R,7aR)-

CAS : 1009816-48-1

Formule : C₉H₁₆N₂O₄S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 248.2993

Ref: IN-DA0003CM

1,2-Dideoxy-2''-ethylamino-α-D-glucopyranoso-[2,1-d]-2''-thiazoline

CAS : 1009816-48-1

Formule : C₉H₁₆N₂O₄S

Masse moléculaire : 248.30

Ref: 7W-GC1002

Thiamet G

CAS : 1009816-48-1

Thiamet G

Formule : C₉H₁₆N₂O₄S

Degré de pureté : ≥98%

Masse moléculaire : 248.3

Ref: 54-BUP09906

Thiamet G

CAS : 1009816-48-1

Thiamet G is a selective O-GlcNAcase inhibitor (Ki=20 nM). The role of O-GlcNAcase is to remove O-GlcNAc from the modified protein. High-Quality, Low-Cost!

Formule : C₉H₁₆N₂O₄S

Degré de pureté : 99.06% - 99.99%

Couleur et forme : White Solid

Masse moléculaire : 248.3

Ref: TM-T6056

Thiamet G

CAS : 1009816-48-1

(3aR,5R,6S,7R,7aR)-2-(Ethylamino)-5-(hydroxymethyl)-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d]thiazole-6,7-diol

Formule : C₉H₁₆N₂O₄S

Degré de pureté : 98%

Masse moléculaire : 248.3

Ref: IN-DG571819

Thiamet G

CAS : 1009816-48-1

Inhibits β-N-acetylglucosaminidase, also known as O-GlcNAcase (OGA), which cleaves the O-linked glycans from glycoproteins. Interferes with O-GlcNAc cycling and leads to the accumulation of O-GlcNAcylated proteins. Thiamet G elicits neuroprotective effects by modulating microglia/macrophages and inhibiting hyperphosphorylation of the microtubule-associated protein tau in models of stroke and Alzheimer’s disease. Thiamet G also has implications on diabetes and cardiovascular pathologies.

Formule : C₉H₁₆N₂O₄S

Degré de pureté : Min. 95%

Couleur et forme : Powder

Masse moléculaire : 248.3 g/mol

Ref: 3D-MD08856

Thiamet G - Bio-X ™

CAS : 1009816-48-1

Thiamet G inhibits β-N-acetylglucosaminidase, also known as O-GlcNAcase (OGA), which cleaves the O-linked glycans from glycoproteins. Interferes with O-GlcNAc cycling and leads to the accumulation of O-GlcNAcylated proteins. Thiamet G elicits neuroprotective effects by modulating microglia/macrophages and inhibiting hyperphosphorylation of the microtubule-associated protein tau in models of stroke and Alzheimer’s disease. Thiamet G also has implications on diabetes and cardiovascular pathologies.

Formule : C₉H₁₆N₂O₄S

Degré de pureté : Min. 95%

Couleur et forme : Powder

Masse moléculaire : 248.3 g/mol

Ref: 3D-BT300146